Monoamine oxidase inhibitor-induced speech blockage.
Speech blockage has been identified by recent case reports as a side effect of tricyclics in the treatment of depression. The first report of speech blockage associated with a monoamine oxidase inhibitor is presented and the possible mechanisms are discussed. All reports, including this one, associate this phenomenon with clinical improvement.
D000328:Adult; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D005260:Female; D006801:Humans; D010624:Phenelzine / Q000009:adverse effects* / Q000627:therapeutic use; D013060:Speech / Q000187:drug effects*; D013850:Thinking / Q000187:drug effects; D014191:Tranylcypromine / Q000009:adverse effects / Q000627:therapeutic use
D014191:Tranylcypromine; D010624:Phenelzine